FOLH1 and neoplasm: These pharmacokinetics result in higher tumor uptake and enhanced tumor-to-background ratios for [18F]RPS-040 and [18F]RPS-041 relative to [68Ga]Ga-PSMA-HBED-CC (Fig. 9).